Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Repare Therapeutics Inc 7171 Frederick-Banting Building 2 Suite 270 St-Laurent A8 H4S 1Z9 CAN

www.reparerx.com Employees: 129 P: 857-412-7018

Sector:

Medical

Description:

Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.

Key Statistics

Overview:

Market Capitalization, $K 111,219
Enterprise Value, $K 26,499
Shares Outstanding, K 43,108
Float, K 38,151
% Float 88.50%
Short Interest, K 352
Short Float 0.82%
Days to Cover 1.00
Short Volume Ratio 0.79
% of Insider Shareholders 11.50%
% of Institutional Shareholders 85.09%

Financials:

Annual Sales, $ 53,480 K
Annual Net Income, $ -84,690 K
Last Quarter Sales, $ 11,620 K
Last Quarter Net Income, $ 3,260 K
EBIT, $ -78,490 K
EBITDA, $ -81,730 K

Growth:

1-Year Return 101.56%
3-Year Return -78.17%
5-Year Return -93.16%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/14/25
Next Earnings Date 03/02/26
Earnings Per Share ttm -1.77
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RPTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -60.15%
Return-on-Assets % -52.24%
Profit Margin % -158.36%
Debt/Equity 0.00
Price/Sales 9.29
Price/Cash Flow N/A
Price/Book 0.96
Book Value/Share 2.68
Interest Coverage -1.68
60-Month Beta 0.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar